Humanetics Corporation
3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 3 name spellings.
8
Ending by 2030
Jun 2029
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 11, 2026The maintenance fee for Suspension compositions of physiologically active phenolic compounds and methods of making and using the same (US 10,314,812) comes due Dec 11, 2026. Unpaid by Jun 11, 2027, it lapses early.
- 1 fee due Jan 21, 2027The maintenance fee for Suspension compositions of physiologically active phenolic compounds and methods of making and using the same (US 9,084,726) comes due Jan 21, 2027. Unpaid by Jul 21, 2027, it lapses early.
- 1 fee due Oct 12, 2027The maintenance fee for Nanoparticle Isoflavone Compositions & Methods of Making and Using the Same (US 9,308,167) comes due Oct 12, 2027. Unpaid by Apr 12, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,951,560 | Isoflavone Nanoparticles and Use Thereof In force · High confidence | In force | High confidence | |
| US 8,551,530 | Nanoparticle isoflavone compositions and methods of making and using the same In force · From the USPTO record | In force | From the USPTO record | |
| US 8,900,635 | Nanoparticle Isoflavone Compositions & Methods of Making and Using the Same In force · High confidence | In force | High confidence | |
| US 9,308,167 | Nanoparticle Isoflavone Compositions & Methods of Making and Using the Same In force · High confidence | In force | High confidence | |
| US 9,636,322 | Nanoparticle Isoflavone Compositions & Methods of Making and Using the Same In force · High confidence | In force | High confidence | |
| US 9,724,325 | Nanoparticle Isoflavone Compositions & Methods of Making and Using the Same In force · Medium confidence | In force | Medium confidence | |
| US 10,039,739 | Nanoparticle Isoflavone Compositions & Methods of Making and Using the Same In force · Medium confidence | In force | Medium confidence | |
| US 10,729,674 | Nanoparticle Isoflavone Compositions & Methods of Making and Using the Same In force · Medium confidence | In force | Medium confidence | |
| US 9,623,003 | Method of mitigating long and short term detrimental effects of exposure to medical imaging ionizing radiation by administration of genistein In force · From the USPTO record | In force | From the USPTO record | |
| US 9,993,455 | Method of mitigating long term detrimental effects of exposure to medical imaging ionizing radiation by administration of genistein In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 18: 3 patents in force now held by others · 13 lapsed for an unpaid fee · 23 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
6 pending · 3 abandoned · 4 no status recorded